Efficacy and Long-term Safety of Elinzanetant for the Treatment of VMS Associated with Menopause: A Phase 3 Randomized Trial (OASIS 3)

Authors
Category Primary study
JournalMenopause
Year 2024
This article has no abstract
Epistemonikos ID: a15a382f7e310a1e7377900f31c4913ef8a12583
First added on: Jan 31, 2025